Global GCC Countries Radiopharmaceutical Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The GCC Countries Radiopharmaceutical is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global GCC Countries Radiopharmaceutical market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the GCC Countries Radiopharmaceutical industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global GCC Countries Radiopharmaceutical Market Segmentations:

    By Players:

    • Jubilant Pharma

    • Dongcheng

    • Mallinckrodt

    • Navidea

    • GE Healthcare

    • Bayer

    • China Isotope & Radiation

    • Bracco Imaging

    • Advanced Accelerator Applications

    • IBA Group

    • Nordion

    • Eli Lilly

    • Lantheus

    • SIEMENS

    • Triad Isotopes

    By Types:

    • Actinium-225

    • Lutetium-177

    • Radium-223

    • Holmium-166

    • Other

    By End-User:

    • Oncology

    • Cardiology

    • Others

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of GCC Countries Radiopharmaceutical Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global GCC Countries Radiopharmaceutical Market Size and Growth Rate of Actinium-225 from 2014 to 2026

      • 1.3.2 Global GCC Countries Radiopharmaceutical Market Size and Growth Rate of Lutetium-177 from 2014 to 2026

      • 1.3.3 Global GCC Countries Radiopharmaceutical Market Size and Growth Rate of Radium-223 from 2014 to 2026

      • 1.3.4 Global GCC Countries Radiopharmaceutical Market Size and Growth Rate of Holmium-166 from 2014 to 2026

      • 1.3.5 Global GCC Countries Radiopharmaceutical Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global GCC Countries Radiopharmaceutical Market Size and Growth Rate of Oncology from 2014 to 2026

      • 1.4.2 Global GCC Countries Radiopharmaceutical Market Size and Growth Rate of Cardiology from 2014 to 2026

      • 1.4.3 Global GCC Countries Radiopharmaceutical Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina GCC Countries Radiopharmaceutical Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of GCC Countries Radiopharmaceutical Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of GCC Countries Radiopharmaceutical by Major Types

      • 3.4.1 GCC Countries Radiopharmaceutical Market Size and Growth Rate of Actinium-225

      • 3.4.2 GCC Countries Radiopharmaceutical Market Size and Growth Rate of Lutetium-177

      • 3.4.3 GCC Countries Radiopharmaceutical Market Size and Growth Rate of Radium-223

      • 3.4.4 GCC Countries Radiopharmaceutical Market Size and Growth Rate of Holmium-166

      • 3.4.5 GCC Countries Radiopharmaceutical Market Size and Growth Rate of Other

    4 Segmentation of GCC Countries Radiopharmaceutical Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of GCC Countries Radiopharmaceutical by Major End-Users

      • 4.4.1 Market Size and Growth Rate of GCC Countries Radiopharmaceutical in Oncology

      • 4.4.2 Market Size and Growth Rate of GCC Countries Radiopharmaceutical in Cardiology

      • 4.4.3 Market Size and Growth Rate of GCC Countries Radiopharmaceutical in Others

    5 Market Analysis by Major Regions

    • 5.1 Global GCC Countries Radiopharmaceutical Production Analysis by Major Regions

    • 5.2 Global GCC Countries Radiopharmaceutical Consumption Analysis by Major Regions

    • 5.3 Global GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

    6 Product Commodity of GCC Countries Radiopharmaceutical Market in Major Countries

    • 6.1 Top 5 Export Countries in GCC Countries Radiopharmaceutical market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in GCC Countries Radiopharmaceutical market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in GCC Countries Radiopharmaceutical market from 2014 to 2019

    • 6.2 Top 5 Import Countries in GCC Countries Radiopharmaceutical market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in GCC Countries Radiopharmaceutical market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in GCC Countries Radiopharmaceutical market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America GCC Countries Radiopharmaceutical Landscape Analysis

    • 7.1 North America GCC Countries Radiopharmaceutical Landscape Analysis by Major Types

    • 7.2 North America GCC Countries Radiopharmaceutical Landscape Analysis by Major End-Users

    • 7.3 North America GCC Countries Radiopharmaceutical Landscape Analysis by Major Countries

      • 7.3.1 United States GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 7.3.2 Canada GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 7.3.3 Mexico GCC Countries Radiopharmaceutical Market Volume and Growth Rate

    8 Europe GCC Countries Radiopharmaceutical Landscape Analysis

    • 8.1 Europe GCC Countries Radiopharmaceutical Landscape Analysis by Major Types

    • 8.2 Europe GCC Countries Radiopharmaceutical Landscape Analysis by Major End-Users

    • 8.3 Europe GCC Countries Radiopharmaceutical Landscape Analysis by Major Countries

      • 8.3.1 Germany GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 8.3.2 UK GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 8.3.3 France GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 8.3.4 Italy GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 8.3.5 Nordic Countries GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 8.3.6 Spain GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 8.3.7 Belgium GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 8.3.8 Poland GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 8.3.9 Russia GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 8.3.10 Turkey GCC Countries Radiopharmaceutical Market Volume and Growth Rate

    9 Asia Pacific GCC Countries Radiopharmaceutical Landscape Analysis

    • 9.1 Asia Pacific GCC Countries Radiopharmaceutical Landscape Analysis by Major Types

    • 9.2 Asia Pacific GCC Countries Radiopharmaceutical Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific GCC Countries Radiopharmaceutical Landscape Analysis by Major Countries

      • 9.3.1 China GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 9.3.2 Japan GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 9.3.4 India GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 9.3.6 South Korea GCC Countries Radiopharmaceutical Market Volume and Growth Rate

    10 Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Landscape Analysis

    • 10.1 Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 10.3.2 Brazil GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 10.3.3 Nigeria GCC Countries Radiopharmaceutical Market Volume and Growth Rate

      • 10.3.4 South Africa GCC Countries Radiopharmaceutical Market Volume and Growth Rate 

      • 10.3.5 Argentina GCC Countries Radiopharmaceutical Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Jubilant Pharma

      • 11.1.1 Jubilant Pharma Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Dongcheng

      • 11.2.1 Dongcheng Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Mallinckrodt

      • 11.3.1 Mallinckrodt Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Navidea

      • 11.4.1 Navidea Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 GE Healthcare

      • 11.5.1 GE Healthcare Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Bayer

      • 11.6.1 Bayer Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 China Isotope & Radiation

      • 11.7.1 China Isotope & Radiation Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Bracco Imaging

      • 11.8.1 Bracco Imaging Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Advanced Accelerator Applications

      • 11.9.1 Advanced Accelerator Applications Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 IBA Group

      • 11.10.1 IBA Group Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Nordion

      • 11.11.1 Nordion Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Eli Lilly

      • 11.12.1 Eli Lilly Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Lantheus

      • 11.13.1 Lantheus Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 SIEMENS

      • 11.14.1 SIEMENS Company Profile and Recent Development

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Triad Isotopes

      • 11.15.1 Triad Isotopes Company Profile and Recent Development

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 109 Figures and 209 Tables)

    • Figure Product Picture

    • Figure GCC Countries Radiopharmaceutical Market Size and Growth Rate of Actinium-225 from 2014 to 2026

    • Figure GCC Countries Radiopharmaceutical Market Size and Growth Rate of Lutetium-177 from 2014 to 2026

    • Figure GCC Countries Radiopharmaceutical Market Size and Growth Rate of Radium-223 from 2014 to 2026

    • Figure GCC Countries Radiopharmaceutical Market Size and Growth Rate of Holmium-166 from 2014 to 2026

    • Figure GCC Countries Radiopharmaceutical Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global GCC Countries Radiopharmaceutical Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Global GCC Countries Radiopharmaceutical Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Global GCC Countries Radiopharmaceutical Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina GCC Countries Radiopharmaceutical Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of GCC Countries Radiopharmaceutical Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of GCC Countries Radiopharmaceutical

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of GCC Countries Radiopharmaceutical by Different Types from 2014 to 2026

    • Table Consumption Share of GCC Countries Radiopharmaceutical by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Actinium-225

    • Figure Market Size and Growth Rate of Lutetium-177

    • Figure Market Size and Growth Rate of Radium-223

    • Figure Market Size and Growth Rate of Holmium-166

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of GCC Countries Radiopharmaceutical by Different End-Users from 2014 to 2026

    • Table Consumption Share of GCC Countries Radiopharmaceutical by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Cardiology

    • Figure Market Size and Growth Rate of Others

    • Table Global GCC Countries Radiopharmaceutical Production by Major Regions

    • Table Global GCC Countries Radiopharmaceutical Production Share by Major Regions

    • Figure Global GCC Countries Radiopharmaceutical Production Share by Major Regions in 2014

    • Figure Global GCC Countries Radiopharmaceutical Production Share by Major Regions in 2018

    • Figure Global GCC Countries Radiopharmaceutical Production Share by Major Regions in 2026

    • Table Global GCC Countries Radiopharmaceutical Consumption by Major Regions

    • Table Global GCC Countries Radiopharmaceutical Consumption Share by Major Regions

    • Figure Global GCC Countries Radiopharmaceutical Consumption Share by Major Regions in 2014

    • Figure Global GCC Countries Radiopharmaceutical Consumption Share by Major Regions in 2018

    • Figure Global GCC Countries Radiopharmaceutical Consumption Share by Major Regions in 2026

    • Table North America GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Europe GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Asia Pacific GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in GCC Countries Radiopharmaceutical market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in GCC Countries Radiopharmaceutical market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in GCC Countries Radiopharmaceutical market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in GCC Countries Radiopharmaceutical market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America GCC Countries Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table North America GCC Countries Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Figure North America GCC Countries Radiopharmaceutical Consumption Share by Types in 2014

    • Figure North America GCC Countries Radiopharmaceutical Consumption Share by Types in 2018

    • Figure North America GCC Countries Radiopharmaceutical Consumption Share by Types in 2026

    • Table North America GCC Countries Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table North America GCC Countries Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Figure North America GCC Countries Radiopharmaceutical Consumption Share by End-Users in 2014

    • Figure North America GCC Countries Radiopharmaceutical Consumption Share by End-Users in 2018

    • Figure North America GCC Countries Radiopharmaceutical Consumption Share by End-Users in 2026

    • Table North America GCC Countries Radiopharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table North America GCC Countries Radiopharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure North America GCC Countries Radiopharmaceutical Consumption Share by Major Countries in 2014

    • Figure North America GCC Countries Radiopharmaceutical Consumption Share by Major Countries in 2018

    • Figure North America GCC Countries Radiopharmaceutical Consumption Share by Major Countries in 2026

    • Figure United States GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Europe GCC Countries Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Europe GCC Countries Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Figure Europe GCC Countries Radiopharmaceutical Consumption Share by Types in 2014

    • Figure Europe GCC Countries Radiopharmaceutical Consumption Share by Types in 2018

    • Figure Europe GCC Countries Radiopharmaceutical Consumption Share by Types in 2026

    • Table Europe GCC Countries Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Europe GCC Countries Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Figure Europe GCC Countries Radiopharmaceutical Consumption Share by End-Users in 2014

    • Figure Europe GCC Countries Radiopharmaceutical Consumption Share by End-Users in 2018

    • Figure Europe GCC Countries Radiopharmaceutical Consumption Share by End-Users in 2026

    • Table Europe GCC Countries Radiopharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Europe GCC Countries Radiopharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe GCC Countries Radiopharmaceutical Consumption Share by Major Countries in 2014

    • Figure Europe GCC Countries Radiopharmaceutical Consumption Share by Major Countries in 2018

    • Figure Europe GCC Countries Radiopharmaceutical Consumption Share by Major Countries in 2026

    • Figure Germany GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure UK GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure France GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific GCC Countries Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Asia Pacific GCC Countries Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific GCC Countries Radiopharmaceutical Consumption Share by Types in 2014

    • Figure Asia Pacific GCC Countries Radiopharmaceutical Consumption Share by Types in 2018

    • Figure Asia Pacific GCC Countries Radiopharmaceutical Consumption Share by Types in 2026

    • Table Asia Pacific GCC Countries Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific GCC Countries Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific GCC Countries Radiopharmaceutical Consumption Share by End-Users in 2014

    • Figure Asia Pacific GCC Countries Radiopharmaceutical Consumption Share by End-Users in 2018

    • Figure Asia Pacific GCC Countries Radiopharmaceutical Consumption Share by End-Users in 2026

    • Table Asia Pacific GCC Countries Radiopharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific GCC Countries Radiopharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific GCC Countries Radiopharmaceutical Consumption Share by Major Countries in 2014

    • Figure Asia Pacific GCC Countries Radiopharmaceutical Consumption Share by Major Countries in 2018

    • Figure Asia Pacific GCC Countries Radiopharmaceutical Consumption Share by Major Countries in 2026

    • Figure China GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandGCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure India GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa GCC Countries Radiopharmaceutical Consumption Share by Major Countries in 2026

    • Figure GCC Countries GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina GCC Countries Radiopharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Jubilant Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant Pharma

    • Figure Sales and Growth Rate Analysis of Jubilant Pharma

    • Figure Revenue and Market Share Analysis of Jubilant Pharma

    • Table Product and Service Introduction of Jubilant Pharma

    • Table Company Profile and Development Status of Dongcheng

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dongcheng

    • Figure Sales and Growth Rate Analysis of Dongcheng

    • Figure Revenue and Market Share Analysis of Dongcheng

    • Table Product and Service Introduction of Dongcheng

    • Table Company Profile and Development Status of Mallinckrodt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt

    • Figure Sales and Growth Rate Analysis of Mallinckrodt

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Product and Service Introduction of Mallinckrodt

    • Table Company Profile and Development Status of Navidea

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Navidea

    • Figure Sales and Growth Rate Analysis of Navidea

    • Figure Revenue and Market Share Analysis of Navidea

    • Table Product and Service Introduction of Navidea

    • Table Company Profile and Development Status of GE Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare

    • Figure Sales and Growth Rate Analysis of GE Healthcare

    • Figure Revenue and Market Share Analysis of GE Healthcare

    • Table Product and Service Introduction of GE Healthcare

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of China Isotope & Radiation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Isotope & Radiation

    • Figure Sales and Growth Rate Analysis of China Isotope & Radiation

    • Figure Revenue and Market Share Analysis of China Isotope & Radiation

    • Table Product and Service Introduction of China Isotope & Radiation

    • Table Company Profile and Development Status of Bracco Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bracco Imaging

    • Figure Sales and Growth Rate Analysis of Bracco Imaging

    • Figure Revenue and Market Share Analysis of Bracco Imaging

    • Table Product and Service Introduction of Bracco Imaging

    • Table Company Profile and Development Status of Advanced Accelerator Applications

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advanced Accelerator Applications

    • Figure Sales and Growth Rate Analysis of Advanced Accelerator Applications

    • Figure Revenue and Market Share Analysis of Advanced Accelerator Applications

    • Table Product and Service Introduction of Advanced Accelerator Applications

    • Table Company Profile and Development Status of IBA Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IBA Group

    • Figure Sales and Growth Rate Analysis of IBA Group

    • Figure Revenue and Market Share Analysis of IBA Group

    • Table Product and Service Introduction of IBA Group

    • Table Company Profile and Development Status of Nordion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion

    • Figure Sales and Growth Rate Analysis of Nordion

    • Figure Revenue and Market Share Analysis of Nordion

    • Table Product and Service Introduction of Nordion

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Lantheus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus

    • Figure Sales and Growth Rate Analysis of Lantheus

    • Figure Revenue and Market Share Analysis of Lantheus

    • Table Product and Service Introduction of Lantheus

    • Table Company Profile and Development Status of SIEMENS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SIEMENS

    • Figure Sales and Growth Rate Analysis of SIEMENS

    • Figure Revenue and Market Share Analysis of SIEMENS

    • Table Product and Service Introduction of SIEMENS

    • Table Company Profile and Development Status of Triad Isotopes

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Triad Isotopes

    • Figure Sales and Growth Rate Analysis of Triad Isotopes

    • Figure Revenue and Market Share Analysis of Triad Isotopes

    • Table Product and Service Introduction of Triad Isotopes


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.